A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, sequential cohorts, flexible dose study to evaluate the tolerability,
safety and pharmacokinetics of iloperidone in elderly patients with Parkinson's disease
psychosis (PDP).